Variables | The tertile of the Gensini scores | The number of stenotic vessels |
---|
| OR | 95 % CI |
P
| OR | 95 % CI |
P
|
---|
TG/HDL-C |
Model 1 | 1.02 | 0.98–1.08 | 0.339 | 1.05 | 1.00–1.10 | 0.033 |
Model 2 | 0.98 | 0.91–1.05 | 0.576 | 1.00 | 0.93–1.07 | 0.983 |
Model 3 a
| 0.98 | 0.91–1.05 | 0.536 | 1.04 | 0.90–1.21 | 0.600 |
LDL-C/HDL-C |
Model 1 | 1.16 | 1.02–1.31 | 0.019 | 1.39 | 1.22–1.58 | <0.001 |
Model 2 | 0.99 | 0.827–1.19 | 0.909 | 1.01 | 0.83–1.22 | 0.960 |
Model 3 b
| 1.13 | 0.77–1.66 | 0.533 | 0.87 | 0.57–1.31 | 0.499 |
TC/HDL-C |
Model 1 | 1.07 | 1.01–1.14 | 0.030 | 1.13 | 1.06–1.21 | <0.001 |
Model 2 | 0.97 | 0.89–1.72 | 0.485 | 0.99 | 0.91–1.08 | 0.888 |
Model 3 b
| 0.87 | 0.65–1.16 | 0.334 | 0.81 | 0.59–1.10 | 0.176 |
ApoB100/apoAI |
Model 1 | 2.73 | 1.60–4.66 | <0.001 | 4.79 | 2.80–8.20 | <0.001 |
Model 2 | 3.18 | 1.30–7.76 | 0.011 | 2.55 | 1.04–6.28 | 0.041 |
Model 3 c
| 2.93 | 1.17–7.34 | 0.022 | 3.14 | 1.01–6.47 | 0.048 |
- Model 1, adjusted for the non-lipid CHD risk factors including age, gender, weight, BMI, smoking, alcohol consumption, diabetes mellitus and hypertension; Model 2, adjusted for the variables in Model 1 plus the individual lipid variables including TG, HDL-C, LDL-C, apoB100 and apoAI; Model 3 a, adjusted for the variables in Model 2 plus the lipoprotein ratios including LDL-C/HDL-C and apoB100/apoAI; Model 3 b, adjusted for the variables in Model 2 plus the lipoprotein ratios including TG/HDL-C and apoB100/apoAI; Model 3 c, adjusted for the variables in Model 2 plus the lipoprotein ratios including TG/HDL-C and LDL-C/HDL-C
-
OR odds ratio, 95 % CI 95 % confidence interval, TG/HDL-C triglyceride/high-density lipoprotein cholesterol, TC/HDL-C total cholesterol/high-density lipoprotein cholesterol, LDL-C/HDL-C low-density lipoprotein cholesterol/high-density lipoprotein cholesterol, apoB100/apoAI apolipoprotein AI/apolipoprotein B100